PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit With the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$PMI—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before April 3, 2026.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Picard was the subject of a manipulation scheme designed to fraudulently boost its share price. The Company and insiders dumped shares at artificially inflated prices. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Picard, investors suffered damages.
Join the case to recover your losses
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
You May Also Like
Top Altcoins To Hold Before 2026 For Maximum ROI – One Is Under $1!
UBS CEO Targets Direct Crypto Access With “Fast Follower” Tokenization Strategy
